Join
STAAR Surgical Company logo

STAA

NASDAQ

STAAR Surgical Company

SectorHealth CareIndustryOphthalmic Goods
$28.22-0.28 (-0.98%)
News25/Ratings12

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Price$28.22-0.25 (-0.88%)
01:45 PM07:45 PM
News · 26 weeks82+233%
2025-12-07: 182025-12-14: 132025-12-21: 02025-12-28: 02026-01-04: 62026-01-11: 62026-01-18: 12026-01-25: 02026-02-01: 62026-02-08: 12026-02-15: 12026-02-22: 22026-03-01: 42026-03-08: 42026-03-15: 32026-03-22: 12026-03-29: 02026-04-05: 32026-04-12: 02026-04-19: 02026-04-26: 02026-05-03: 32026-05-10: 62026-05-17: 42026-05-24: 02026-05-31: 0
2025-12-072026-05-31
Mix2490d
  • Insider12(50%)
  • SEC Filings5(21%)
  • Other4(17%)
  • Analyst2(8%)
  • Earnings1(4%)

Latest news

25 items

STAA FAQ

6 questions
  • What does STAAR Surgical Company do?
    STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related...
  • Where does STAA stock trade?
    STAAR Surgical Company (STAA) is listed on NASDAQ.
  • What sector and industry is STAA in?
    STAAR Surgical Company operates in the Health Care sector, Ophthalmic Goods industry.
  • What are analysts saying about STAA?
    STAAR Surgical Company has had 8 recent analyst actions on file. The most recent action was from Wedbush: Outperform with a $4000.00 price target on 2026-05-14. Recent price targets range from $1300.00 to $4000.00.
  • What companies are similar to STAA?
    Notable peers in the same industry include ALC (Alcon Inc.), COO (The Cooper Companies Inc.), BLCO (Bausch + Lomb Corporation), WRBY (Warby Parker Inc.), EYE (National Vision Holdings Inc.). Compare STAA side-by-side with any of them on Quantisnow.
  • How can I track STAA on Quantisnow?
    Quantisnow aggregates STAAR Surgical Company's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow STAA to receive live email and push alerts on every new disclosure.